Skip to main content
OpenTrials

Clinical trial condition

Bone Marrow Neoplasms

Explore clinical trials studying Bone Marrow Neoplasms. Study availability and eligibility vary by location and protocol.

206 public trials 34 recruiting studies
Refine in advanced search Browse all conditions

Bone Marrow Neoplasms trial results

Completed

Ruxolitinib Efficacy and Safety in Patients With HU Resistant or Intolerant Polycythemia Vera vs Best Available Therapy.

NCT02038036

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +6 more
Locations
  • Novartis Investigative Site Herston, Queensland, Australia
  • Novartis Investigative Site Antwerp, Belgium
  • Novartis Investigative Site Leuven, Belgium
  • Novartis Investigative Site Toronto, Ontario, Canada
View all 48 locations
View Trial Details
Completed

PD-1 Inhibition in Advanced Myeloproliferative Neoplasms

NCT03065400

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Chronic Phase Myelofibrosis, +9 more
Locations
  • Harvard Medical School Massachusetts General Hospital Boston, Massachusetts, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
  • Montefiore Medical Center Division of Hematology, Department of Oncology The Bronx, New York, United States
View Trial Details
Completed

Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial

NCT00750009

Conditions
Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +106 more
Locations
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
  • Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
  • Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States
  • Fox Chase Cancer Center - Philadelphia Philadelphia, Pennsylvania, United States
View Trial Details
Completed

A Phase Ib/II Dose-finding Study to Assess the Safety and Efficacy of LDE225 + INC424 in Patients With MF

NCT01787552

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +13 more
Locations
  • Novartis Investigative Site Camperdown, New South Wales, Australia
  • Novartis Investigative Site Woolloongabba, Queensland, Australia
  • Novartis Investigative Site Leuven, Belgium
  • Novartis Investigative Site Toronto, Ontario, Canada
View all 18 locations
View Trial Details

Related conditions